Genfit S.A. (GNFT)
NASDAQ: GNFT · Real-Time Price · USD
3.840
+0.010 (0.26%)
Feb 24, 2025, 10:29 AM EST - Market open
Genfit Employees
Genfit had 159 employees as of December 31, 2023. The number of employees increased by 11 or 7.43% compared to the previous year.
Employees
159
Change (1Y)
11
Growth (1Y)
7.43%
Revenue / Employee
$542,297
Profits / Employee
$150,079
Market Cap
192.83M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
GNFT News
- 3 days ago - GENFIT Announces the Preliminary Results of the Repurchase Offer to 2025 OCEANEs holders and the Convening of the 2025 OCEANEs holders' general meeting - GlobeNewsWire
- 9 days ago - GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders - GlobeNewsWire
- 17 days ago - GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025 - GlobeNewsWire
- 25 days ago - GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan - GlobeNewsWire
- 25 days ago - GENFIT Announces 2025 Financial Calendar - GlobeNewsWire
- 5 weeks ago - GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial - GlobeNewsWire
- 3 months ago - GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024 - GlobeNewsWire
- 3 months ago - GENFIT Reports Third Quarter 2024 Financial Information - GlobeNewsWire